TABLE 1.
Characteristic | Overall (N = 277) | Without obesity, BMI ≤ 29.9 (n = 139) | Class 1, BMI 30‐34.9 (n = 77) | Class 2, BMI 35‐39.9 (n = 32) | Class 3, BMI ≥ 40 (n = 29) | All with obesity, BMI ≥ 30 (n = 138) | P (“Without obesity” to “All with obesity”) |
---|---|---|---|---|---|---|---|
Age, median (IQR) | 60 (49‐72) | 66 (54‐76) | 58 (48‐68) | 53 (41‐60) | 58 (45‐68) | 56 (46‐66) | <0.05 |
Male | 175 (63) | 93 (67) | 48 (62) | 20 (63) | 14 (48) | 0.12 | |
Ethnicity | |||||||
Hispanic or Latino | 111 (40) | 48 (35) | 42 (55) | 10 (31) | 11 (38) | 63 (46) | |
Non‐Hispanic or Latino | 123 (44) | 69(50) | 29 (38) | 12 (38) | 13 (45) | 54 (39) | 0.012 |
Unknown | 43 (16) | 22 (16) | 6 (8) | 10 (31) | 5 (17) | 21 (15) | |
Race | |||||||
Black or African American | 32 (12) | 22 (16) | 4 (5) | 2 (6) | 4 (14) | 10 (7) | |
American Indian or Alaska Native | 1 (0.4) | 0 (0) | 0 (0) | 1 (3) | 0 (0) | 1 (<1) | |
Asian | 10 (4) | 4 (3) | 4 (5) | 2 (6) | 0 (0) | 6 (4) | 0.19 |
Native Hawaiian or other Pacific Islander | 2 (0.7) | 1 (1) | 1 (1) | 0 (0) | 0 (0) | 1 (<1) | |
White or Caucasian | 93 (34) | 51 (37) | 23 (30) | 11 (34) | 8 (28) | 42 (30) | |
Other | 139 (50) | 61 (44) | 45 (58) | 16 (50) | 17 (59) | 78 (57) | |
Comorbidities | |||||||
CAD | 27 (10) | 13 (9) | 11 (14) | 2 (6) | 1 (3) | 14 (10) | 0.37 |
HF | 30 (11) | 18 (13) | 3 (4) | 2 (6) | 7 (24) | 12 (9) | <0.05 |
HTN | 135 (49) | 69 (50) | 42 (55) | 17 (53) | 14 (48) | 73 (53) | 0.67 |
DM | 111 (40) | 53 (38) | 32 (42) | 13 (41) | 13 (45) | 58 (42) | 0.59 |
CKD | 40 (14) | 24 (17) | 9 (12) | 2 (6) | 5 (17) | 16 (12) | 0.37 |
Pulmonary disease | 53 (19) | 21 (15) | 18 (23) | 4 (13) | 10 (34) | 32 (23) | 0.05 |
Immunocompromise | 19 (7) | 12 (9) | 5 (6) | 0 (0) | 2 (7) | 7 (5) | 0.41 |
Malignancy | 33 (12) | 17 (12) | 9 (12) | 2 (6) | 5 (17) | 16 (12) | 0.62 |
Ever smoker (former and current) | 111 (40) | 64 (46) | 23 (30) | 11 (34) | 13 (45) | 47 (34) | 0.05 |
Data given as n (%) unless otherwise specified. CAD, coronary artery disease; CKD, chronic kidney disease; DM, diabetes mellitus; HF, heart failure; HTN, hypertension; IQR, interquartile range.